Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights.

J Hepatocell Carcinoma · 2023 · PMC10362916 · PMID 37483311

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Also, baseline high s-c KIT and low HGF levels showed a trend toward survival benefit in the sorafenib compared to placebo arm, which suggests that they could be used as potential predictive biomarkers for sorafenib. 69 Another sorafenib biomarker study with analyses from a combined SHARP and Asia-Pacific pool revealed high AFP and neutrophil to lymphocyte ra

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.